$DVAX
DYNAVAX TECHNOLOGIES CORP

2017 Q2 Form 10-Q Financial Statement

#000156459018019928 Filed on August 07, 2018

View on sec.gov

Income Statement

Concept 2017 Q2
Revenue $105.0K
YoY Change -96.03%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.980M
YoY Change -42.82%
% of Gross Profit
Research & Development $14.81M
YoY Change -34.9%
% of Gross Profit
Depreciation & Amortization $880.0K
YoY Change 60.0%
% of Gross Profit
Operating Expenses $19.80M
YoY Change -12.97%
Operating Profit
YoY Change
Interest Expense $240.0K
YoY Change 9.09%
% of Operating Profit
Other Income/Expense, Net -$230.0K
YoY Change -560.0%
Pretax Income -$20.32M
YoY Change -29.91%
Income Tax
% Of Pretax Income
Net Earnings -$20.32M
YoY Change -29.9%
Net Earnings / Revenue -19350.48%
Basic Earnings Per Share
Diluted Earnings Per Share -$408.9K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $127.0M
YoY Change -8.63%
Cash & Equivalents $37.68M
Short-Term Investments $89.30M
Other Short-Term Assets $4.400M
YoY Change -30.16%
Inventory
Prepaid Expenses
Receivables $800.0K
Other Receivables $0.00
Total Short-Term Assets $132.2M
YoY Change -10.13%
LONG-TERM ASSETS
Property, Plant & Equipment $16.80M
YoY Change -3.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $900.0K
YoY Change -10.0%
Total Long-Term Assets $19.80M
YoY Change -3.41%
TOTAL ASSETS
Total Short-Term Assets $132.2M
Total Long-Term Assets $19.80M
Total Assets $152.0M
YoY Change -9.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $700.0K
YoY Change -84.44%
Accrued Expenses $10.40M
YoY Change -56.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.10M
YoY Change -60.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $400.0K
YoY Change -33.33%
Total Long-Term Liabilities $400.0K
YoY Change -33.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.10M
Total Long-Term Liabilities $400.0K
Total Liabilities $11.40M
YoY Change -60.42%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $140.5M
YoY Change
Total Liabilities & Shareholders Equity $152.0M
YoY Change -9.31%

Cashflow Statement

Concept 2017 Q2
OPERATING ACTIVITIES
Net Income -$20.32M
YoY Change -29.9%
Depreciation, Depletion And Amortization $880.0K
YoY Change 60.0%
Cash From Operating Activities -$17.39M
YoY Change -31.62%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K
YoY Change -99.57%
Acquisitions
YoY Change
Other Investing Activities -$25.39M
YoY Change -285.33%
Cash From Investing Activities -$25.40M
YoY Change -322.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 58.66M
YoY Change 293200.0%
NET CHANGE
Cash From Operating Activities -17.39M
Cash From Investing Activities -25.40M
Cash From Financing Activities 58.66M
Net Change In Cash 15.87M
YoY Change -213.28%
FREE CASH FLOW
Cash From Operating Activities -$17.39M
Capital Expenditures -$10.00K
Free Cash Flow -$17.38M
YoY Change -24.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12084000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1419000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
253000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32544000
us-gaap Net Income Loss
NetIncomeLoss
-78402000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-624000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
45787000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1254000
CY2017Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105000
us-gaap Restructuring Charges
RestructuringCharges
2783000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38294000
us-gaap Interest Expense
InterestExpense
3852000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-45000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1658000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1674000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
24000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
681000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
35000
dvax Reversal Of Deferred Rent Upon Lease Amendment
ReversalOfDeferredRentUponLeaseAmendment
209000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
4715000
dvax Non Cash Interest Expense
NonCashInterestExpense
1139000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
450000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-532000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4800000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
186000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1642000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
834000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-81000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1623000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2934000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1330000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1664000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-63799000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42642000
dvax Payments To Acquire Technology Licenses
PaymentsToAcquireTechnologyLicenses
9500000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
186821000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
93045000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
165450000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
60875000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1639000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
242000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32510000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32412000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
99000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
88200000
dvax Tax Withholdings Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
TaxWithholdingsProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
-549000
dvax Tax Withholdings Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
TaxWithholdingsProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
-303000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
255000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
155000
us-gaap Interest Paid Net
InterestPaidNet
2713000
dvax Release Of Accrual For Litigation Settlement And Insurance Recovery
ReleaseOfAccrualForLitigationSettlementAndInsuranceRecovery
4050000
dvax Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
42000
dvax Noncash Or Part Noncash Acquisition Of Technology License
NoncashOrPartNoncashAcquisitionOfTechnologyLicense
12773000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
98706000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
88052000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-260000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
405000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2137000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13403000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27213000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24891000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29350000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
216000000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q2 us-gaap Fair Value Equity Level1 To Level2 Transfers Amount
FairValueEquityLevel1ToLevel2TransfersAmount
0
CY2018Q2 us-gaap Fair Value Equity Level2 To Level1 Transfers Amount
FairValueEquityLevel2ToLevel1TransfersAmount
0
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37675000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24289000
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
619000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
602000
CY2018Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
216127000
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
191934000
CY2018Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2018Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
91000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
80000
CY2018Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
216043000
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
191854000
CY2018Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
187401000
CY2018Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
0
CY2018Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
187401000
CY2018Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
187317000
CY2018Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
0
CY2018Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
187317000
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2018Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
2337000
CY2018Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
2266000
CY2017Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
312000
CY2018Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
509000
CY2018Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
22273000
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2500000
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5909000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1194000
CY2018Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16364000
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1306000
CY2018Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
2300000
CY2018Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
700000
CY2017Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
400000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1400000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1000000
CY2018Q2 us-gaap Deferred Rent Credit
DeferredRentCredit
900000
CY2017Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
600000
CY2018Q1 dvax Amount Available For Borrowing Under Long Term Debt Agreement
AmountAvailableForBorrowingUnderLongTermDebtAgreement
175000000
CY2018Q1 dvax Secured Long Term Debt Noncurrent Plus Interest In Kind
SecuredLongTermDebtNoncurrentPlusInterestInKind
100700000
CY2018Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-12-31
us-gaap Loss Contingency Settlement Agreement Date
LossContingencySettlementAgreementDate
September 7, 2016
CY2018Q2 dvax Product Revenue Allowance And Remaining Reserves Classified As Accrued Liabilities
ProductRevenueAllowanceAndRemainingReservesClassifiedAsAccruedLiabilities
300000
CY2018Q2 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2017Q2 us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Dilutive Securities
DilutiveSecurities
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3555000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2110000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
30000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5481000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5215000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2659000
CY2017Q4 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
19.56
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
16.87
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
14.25
CY2018Q2 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
18.50
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
18.57
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.04
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M28D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y10M13D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M14D
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2373000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2302000
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1420000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6290000
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3363000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11089000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7184000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
600000
CY2017Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.40

Files In Submission

Name View Source Status
0001564590-18-019928-index-headers.html Edgar Link pending
0001564590-18-019928-index.html Edgar Link pending
0001564590-18-019928.txt Edgar Link pending
0001564590-18-019928-xbrl.zip Edgar Link pending
dvax-10q_20180630.htm Edgar Link pending
dvax-20180630.xml Edgar Link completed
dvax-20180630.xsd Edgar Link pending
dvax-20180630_cal.xml Edgar Link unprocessable
dvax-20180630_def.xml Edgar Link unprocessable
dvax-20180630_lab.xml Edgar Link unprocessable
dvax-20180630_pre.xml Edgar Link unprocessable
dvax-ex311_10.htm Edgar Link pending
dvax-ex312_12.htm Edgar Link pending
dvax-ex321_8.htm Edgar Link pending
dvax-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending